angiogeneseremmer
antineoplastisch middel
monoklonaal antilichaam
Vascular endothelial growth factor receptor antagonist
|
|
|
|
bevacizumab (substantie)
bevacizumab
Bevacizumab
Id
409406007
Status
Primitive
Has disposition
angiogeneseremmer
Has disposition
Vascular endothelial growth factor receptor antagonist